SCHEMBL9412582

SCHEMBL9412582

COC(=O)CCCSc1ccc2nc(CCC3CCNCC3)n(C)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 5/20 0.38
▸ PDE3A Q14432 5/20 0.38
▸ P2RY12 Q9H244 4/20 0.38
▸ PDE2A O00408 2/20 0.38
▸ ACACB O00763 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ NPY1R P25929 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ NTRK1 P04629 2/20 0.33
▸ NTRK2 Q16620 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL9412454 0.89 HDAC6 (0.40) PDE3BPDE3AP2RY12PDE2AACACB
SCHEMBL9412499 0.86 PDE3B (0.52) PDE3BPDE3AP2RY12PDE2ANPY1R
SCHEMBL9412497 0.82 CNR2 (0.42) PDE3BPDE3AP2RY12PDE2AALDH1A1
SCHEMBL9412644 0.81 PDE3B (0.35) PDE3BPDE3AP2RY12PDE2AACACB
SCHEMBL9412536 0.80 ITGB3 (0.46) SMN1; SMN2ITGB3ITGA2B
SCHEMBL9412664 0.79 PDE3B (0.42) PDE3BPDE3AP2RY12PDE2AALDH1A1
SCHEMBL9412731 0.77 KDM4E (0.52) ALDH1A1MEN1KMT2ARAB9ATP53
SCHEMBL9412511 0.77 MAPT (0.45) RAB9ALMNATP53SMN1; SMN2ITGB3
Bromide SCHEMBL9412485 0.76 PDE3B (0.50) PDE3BPDE3AP2RY12PDE2ANPY1R
SCHEMBL9412623 0.74 MAPT (0.46) RAB9ASMN1; SMN2ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0611660-A2 Condensed 5-membered heterocycles, process for their preparation and medicines containing these compounds Dr. Karl Thomae GmbH (DE) 1994-08-24 — — EP disclosed
Send feedback